Trials / Unknown
UnknownNCT04957888
Microbial Markers for AGI
Investigation on the Microbial Biomarkers of AGI in the Early Stage
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 584 (actual)
- Sponsor
- Peking University Third Hospital · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- —
Summary
AGI is very common in ICU and sometimes will trigger the development of gut derived sepsis. Thus, to find out the biomarker in early stage is very important to improve the overall prognosis of critically ill patients. In this project we try to find out the microbial biomarker of AGI through multi-omic technology.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | none intervention | none intervention. |
Timeline
- Start date
- 2020-07-01
- Primary completion
- 2021-06-01
- Completion
- 2021-07-01
- First posted
- 2021-07-12
- Last updated
- 2021-07-12
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04957888. Inclusion in this directory is not an endorsement.